Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma.

BMC Med Res Methodol · 2025 · PMC11786573 · PMID 39893424

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, these differed from those assuming log-normal or log-logistic distributions, which in turn were fairly similar to each other and showed a trend towards a plateau.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.